Lyka Labs Ltd.
| BSE: 500259 | Sector: Health care |
| NSE: LYKALABS | ISIN Code: INE933A01014 |
| BSE 00:00 | 18 Sep | 19.20 |
-0.10 (-0.52%) |
OPEN
19.50 |
HIGH
19.80 |
LOW
19.00 |
| NSE 00:00 | 18 Sep | 19.10 |
-0.20 (-1.04%) |
OPEN
19.75 |
HIGH
19.80 |
LOW
18.95 |
| OPEN | 19.50 |
| PREVIOUS CLOSE | 19.30 |
| VOLUME | 2211 |
| 52-Week high | 24.85 |
| 52-Week low | 9.70 |
| P/E | |
| Mkt Cap.(Rs cr) | 55 |
| Buy Price | 19.00 |
| Buy Qty | 997.00 |
| Sell Price | 20.25 |
| Sell Qty | 1029.00 |
Lyka Labs Ltd. (LYKALABS) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 523.25 | 11.40 | 2.23 | 3211.14 |
| Dr Reddy's Labs | 5326.70 | 500.10 | 10.36 | 2937.70 |
| Cipla | 806.85 | 54.80 | 7.29 | 2318.17 |
| Aurobindo Pharma | 828.40 | 17.35 | 2.14 | 1872.74 |
| Cadila Health. | 409.15 | 14.95 | 3.79 | 1412.90 |
| Divi's Lab. | 3347.20 | 136.05 | 4.24 | 1372.71 |
| Glenmark Pharma. | 508.65 | 16.30 | 3.31 | 1354.55 |
| Alkem Lab | 2856.80 | 17.90 | 0.63 | 1264.42 |
| Alembic Pharma | 961.70 | -12.55 | -1.29 | 969.40 |
| Torrent Pharma. | 2873.60 | 35.15 | 1.24 | 938.51 |
| P & G Health Ltd | 5271.15 | -118.85 | -2.21 | 838.72 |
| Lupin | 1085.50 | 47.55 | 4.58 | 727.55 |
| Natco Pharma | 888.50 | 112.05 | 14.43 | 667.10 |
| Ipca Labs. | 2172.85 | 25.00 | 1.16 | 652.46 |
| Abbott India | 16512.90 | 71.35 | 0.43 | 592.93 |
| Fortis Health. | 133.25 | -1.30 | -0.97 | 513.33 |
| Pfizer | 4986.05 | 30.25 | 0.61 | 509.13 |
| Apollo Hospitals | 1828.75 | 51.40 | 2.89 | 470.30 |
| Granules India | 365.20 | 1.20 | 0.33 | 444.07 |
| Ajanta Pharma | 1615.45 | 74.45 | 4.83 | 441.13 |
Quick Links for Lyka Labs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
